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mitochondria-mediated apoptosis
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Walter Malorni 1,8, Stefano Salvioli4,5 and Anna Ruggieri1
Abstract
Sex dimorphism in cell response to stress has previously been investigated by different research groups. This
dimorphism could be at least in part accounted for by sex-biased expression of regulatory elements such as
microRNAs (miRs). In order to spot previously unknown miR expression differences we took advantage of prior
knowledge on specialized databases to identify X chromosome-encoded miRs potentially escaping X chromosome
inactivation (XCI). MiR-548am-5p emerged as potentially XCI escaper and was experimentally verified to be
significantly up-regulated in human XX primary dermal fibroblasts (DFs) compared to XY ones. Accordingly, miR-
548am-5p target mRNAs, e.g. the transcript for Bax, was differently modulated in XX and XY DFs. Functional analyses
indicated that XY DFs were more prone to mitochondria-mediated apoptosis than XX ones. Experimentally induced
overexpression of miR548am-5p in XY cells by lentivirus vector transduction decreased apoptosis susceptibility,
whereas its down-regulation in XX cells enhanced apoptosis susceptibility. These data indicate that this approach
could be used to identify previously unreported sex-biased differences in miR expression and that a miR identified
with this approach, miR548am-5p, can account for sex-dependent differences observed in the susceptibility to
mitochondrial apoptosis of human DFs.
Introduction
A number of diseases have been documented to show a
different incidence, progression, and even response to
therapy between women and men. Among these are
cardiovascular, cancer, metabolic, infectious, or immune
diseases1–5. However, albeit the impact of chromosomal
differences has been suggested, relatively few studies have
investigated whether sex chromosomes could play a role6.
In fact, also the association analyses conducted with more
recent DNA sequencing tools have very often neglected to
consider the influence of sex, i.e. the X and Y chromo-
somes, on gene expression7,8. The importance of such a
field of investigation resides on the idea that the under-
standing of the mechanisms underlying gender disparity
could help in our knowledge of the pathogenetic
mechanisms as well as in the development of the so-called
precision medicine9–11. Some insights are derived from
studies carried out at cellular level, as suggested by NIH as
necessary step to fill the gap12,13. Differences in the
behavior of cells from males and females have been
investigated in the recent years as concerns their home-
ostasis. In particular, a series of studies have been carried
out with the aim of deciphering whether a disparity in the
response to stress could take place in cells coming from
males and females. XX and XY cells, independently from
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their origin (e.g. mice, rats, and humans) and histotype
(e.g. muscular and endothelial vessel cells, cardiomyo-
cytes, neurons, fibroblasts), display different responses to
stress: XX cells are more prone to autophagic cytopro-
tection and senescence, whereas XY cells easier undergo
apoptosis14–17. Hence, as a general rule, under the same
stress, e.g. oxidative, a sex disparity can be found in a
series of intracellular parameters of importance in
cell fate.
On these bases the idea that “cell sex” could determine
the answer of a cell type to altered environmental con-
ditions and become a determinant in disease onset or
progression and in response to therapy has been proposed
by recent studies18. This matter belongs to the so-called
gender medicine, a field of investigation that encompasses
several areas of research including immunity/auto-
immunity, cardiovascular diseases, neurodegeneration,
and cancer19–22. In all these pathologic conditions cell
homeostasis (of lymphocytes, vessel or cardiac cells,
neuronal cells, cancer cells), i.e. the control of cell survival
or death, is critical. Hence, the discovery of sex-based
differences in cell’ response to exogenous stressing agents
could possibly provide clues on both the pathogenic
mechanisms of diseases displaying a gender disparity and
on the different response to therapy that has been
observed9.
Evidence is accumulating for a sex-biased expression of
regulatory elements such as microRNA (miRs) across a
variety of tissues that could have functional implica-
tions23,24. The reasons for such differences are at present
not totally clear. One straight-forward hypothesis is that
some of them are encoded in sex chromosomes. To date,
only two miRs are reported to be present in the Y chro-
mosome (miR-3690 and miR-6089), and both are also
present in the X chromosome (NCBI gene database).
On the contrary, the X chromosome is a rather popu-
lated one, and contains about 10% of the total miRs25.
According to the rule of gene dosage, the number of genes
active in each cell should be the same, no matter whether
it is XX or XY, due to the fact that one of the two X
chromosomes is inactivated in female’ cells. However, it is
well known that a number of X-linked genes escape X
chromosome inactivation (XCI)26–28. Recently, it has been
shown that an incomplete XCI affects 23% of X chro-
mosome genes29. A systematic bioinformatic analysis of
these genes has not been performed, due to the extremely
heterogeneous scenario of XCI (escaper genes may display
different levels of expression between tissues and sub-
jects)30. However, incomplete XCI has been proposed as a
mechanism that can introduce phenotypic diversity31,32.
In the same vein, it has been proposed that some of the X-
linked miRs may escape XCI as well, and can be differ-
ently expressed in XX and XY cells, thus accounting (at
least partially) for the observed sex-dependent differences
in immune and stress responses25. In particular, some
miRs are actually coded within the body of escaper genes
and are therefore likely to be regulated in the same way.
We therefore performed an extensive data exploration
via specialised and cross-linked databases to identify miRs
differentially expressed between XX and XY cells that can
account for cell-sex disparity. In particular, (i) we identi-
fied genes that always appear to escape XCI in many
different tissues; (ii) we investigated the presence of miRs
within the region of such genes; (iii) we extracted from
databases the experimentally validated targets of these
miRs and performed a pathway enrichment; (iv) we
experimentally tested the results by checking with quan-
titative real-time PCR the expression of selected target
genes, as well as their biologic functional effects on cell
fate; and finally (v) performed overexpression and silen-
cing experiments of the identified miR (548am-5p) to
validate its possible role in sex-specific phenotypic
difference.
Materials and methods
Selection of XCI escaper genes from available datasets
We used two main data sources about genes escaping X
chromosome inactivation (XCI), hereinafter XCI escaper
genes: the analyses of Carrel and Willard26 and of Cotton
et al.30.
In the above-mentioned papers, genes are defined as
follows. According to the work of Carrel and Willard26
and its Supplementary Table S3, genes escaping X inac-
tivation are expressed in at least 7 out of the 9 hybrid cell
lines tested (genes expressed in 0 to 2 out of 9 hybrid lines
tested are X inactivated; genes expressed in 3 to 6 out of 9
hybrid lines tested are subject to variable escape).
In the study of Cotton et al.30, specifically in the
Additional file 7, Table S5, genes are defined escapers
based on the percentage of inactive X chromosome
expression as a ratio of active X chromosome expression.
According to the above definitions and data, we found
99 escaper genes IDs in the analyses of Carrel and Will-
ard.26 (expressed in ≥7 of the 9 lines tested, hereinafter
Carrel dataset, Table S1), which mapped to 64 valid gene
name IDs after cross-check on HGNC Multi-symbol
checker33, and 68 escaper genes IDs in Cotton et al.,
which mapped to 65 valid gene name IDs after check on
HGNC (hereinafter Cotton dataset, Table S2). Twenty-
three escaper genes are shared between the two datasets
(intersection), while 106 escaper genes appear at least in
one of the two datasets (union; Table S3).
Identification of X-linked miRs putatively escaping XCI
Analysis performed on the 106 genes defined as XCI
escaper in either the Carrell dataset or the Cotton dataset
identified 6 genes that contain 12 miRs in their chromo-
somic loci (Table 1), according to the host gene-miRNA
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mapping services. To do this, we mapped escaper genes
(Uniprot AC) to transcripts (Ensembl Transcript ID,
ENST) by using the Uniprot Knowledgebase mapping
services34 (Table S4), and the X chromosome miR IDs to
the host gene transcripts IDs (Ensemble Transcript ID) by
using the specific services provided by the databases
mirWalk 2.0 (ref. 35) and miRBase36 (Table S5). The
database miRBase provides 118 Homo sapiensmiRNAs on
chromosome X; from these IDs, we obtained the miR IDs
to Ensembl Transcript IDs map by using the “host gene”
mapping service provided by the database mirWalk 2.0.
(Table S5). We finally obtained the list of escaper genes
hosting an miR in their locus (Table S6).
Since for further biological validation experiments we
decided to use primary dermal fibroblasts (DFs), we took
advantage of the dataset by Tukiainen et al.29, in which
the difference in the expression of 681 X -chromosome
genes between males and females in 29 human tissues is
reported. According to this study, three genes out of six of
Table 1 are not expressed in fibroblasts (CSF2RA,
HTR2C, VGLL1), one has a negative Log Fold Change
(GABRE), suggesting that in these cells this gene is not
really escaping XCI. The two remaining genes appear
actually escapers in fibroblasts (CTPS2 and PUDP), so we
focused on these two genes. CTPS2 gene has two miRs in
its locus (miR-548am-5p and 548am-3p), while PUDP
only one (miR-4767). From our previous data, XX and XY
cells differ in terms of susceptibility to apoptosis13,37,38
thus we focused our attention on this aspect. According to
the database Tarbase 8.0 (ref. 39), miR548am-5p has 332
experimentally validated target genes (Table S7). Pathway
analysis carried out with the same knowledgebase via
mirPath v.3 (ref. 40) on such 332 genes yielded six enri-
ched pathways, among which apoptosis (Table S8).
According to KEGG pathway analysis via mirPath, eight
genes are involved in apoptosis (APAF1, ATM, BAX,
CAPN2, PIK3R1, PRKAR2B, TNFRSF10B, and XIAP, p
value= 0.01340305) (Tables S7 and S8). On the same
database Tarbase 8.0, miR-4767 has only three validated
target genes (Table S7). Therefore, miR548am-5p seemed
a good candidate to explain the sex-specific difference in
susceptibility to apoptosis and was therefore selected for
further analyses. Two additional X chromosome miRs
present in loci subject to XCI were also selected as
negative controls: miR-23c and miR-548ax (this latter
belonging to the same family of miR-548am-5p).
Cell culture and treatments
Primary DF cultures were available at the bio-bank of
our laboratory and were established from biopsies of sun-
protected forearm skin according to standard culture
methods. All the donors gave their informed consent
before biopsy was performed. In total, 16 subjects were
studied: 8 female donors (31.37 ± 9.47 years) and 8 male
donors (30.25 ± 4.7 years). DFs cultures were established
and grown-propagated in Dulbecco’s modified Eagle’s
medium (DMEM) (Life technologies, Carlsbad, California,
USA) containing 25mM glucose supplemented with 10%
fetal bovine serum (FBS) (Life technologies, Carlsbad,
California, USA) at 37 °C in a humidified atmosphere of
5% CO2. In addition, the medium contained 100 U/ml
penicillin, 100 μg/ml streptomycin (Life technologies,
Carlsbad, California, USA), 4 mM glutamine, and 1mM
pyruvate. Apoptosis was induced by treating cells with
cycloheximide (CHX, 25 μg/ml) for 2 h and with tumor
necrosis factor-alpha (TNF-α, 100 ng/ml) for additional
18 h. As alternative apoptosis inducer, we also used
Staurosporine (Sigma, 50 nM overnight). All the analyses
were performed on cells between fourth and 12th passage
of culture and at nearly 80% confluence. To note, to
exclude that the observed differences between XX and XY
DFs were due, at least in part, to the effect of the estrogens
and/or testosterone present in the fetal calf serum, we
conducted parallel evaluations also using charcodylated
serum. The results obtained were completely overlapping
(data not shown). Therefore, on these bases, the whole
study was carried out by using non-charcodylated serum.
Quantitative analysis of the selected microRNAs by
TaqMan qRT-PCR
Total RNA, including miRs, was isolated from DFs
using the miRvana Paris Kit (Thermo Fisher), according
to the manufacturer’s instructions. RNA samples, after
quality and quantity evaluation using a NanoDrop ND-
1000 spectrophotometer, were stored at −80 °C until used
in the experiments. Quantification of miR-23c, miR-
Table 1 Escaper genes hosting an miRNA in their locus
Gene miRNA
CSF2RA hsa-miR-3690
CTPS2 hsa-miR-548am
GABRE hsa-miR-224
GABRE hsa-miR-452
HTR2C hsa-miR-1264
HTR2C hsa-miR-1298
HTR2C hsa-miR-1911
HTR2C hsa-miR-1912
HTR2C hsa-miR-448
HTR2C hsa-miR-764
PUDP hsa-miR-4767
VGLL1 hsa-miR-934
Gene names, alphabetical order; black: escaper in Cotton et al.30 (2013); bold:
escaper in Carrel and Willard26; italics: escaper in both datasets
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548am-5p, miR-548ax, and RNU6B and RNU44 (the two
latter as housekeeping miRs, were used for normalization)
expression was carried out in triplicate using specific
inventoried TaqMan MicroRNA Assays (Thermo Fisher),
according to the manufacturer’s instructions. Briefly,
10 ng of RNA was retrotranscribed by the Taq-Man®
MicroRNA Reverse Transcription (RT) Kit (Thermo
Fisher) using individual miR-specific RT primers, and
1.3 μl of RT product was analyzed by quantitative real-
time PCR (qRT-PCR) on the ABI7000 (Applied Biosys-
tem). Threshold cycle (Ct) and baselines were determined
by manual settings. miR expression was calculated by
relative quantification and fold expression changes were
determined by the 2−ΔΔCt method, after normalization to
the RNU6B and RNU44 ΔCt. 1.5 miRs fold changes
between female and male cells were considered
significant.
Lentivirus production
The 293 GPR cells were used as HIV-1 packaging cells
for lentivirus production. In these cells, gag-pol genes are
expressed under control of an ecdysone-inducible pro-
moter, so that the lentiviral particle production requires
cell stimulation with the ecdysone analog ponasterone A
(PonA). Lentivirus (LVS) were obtained by co-transfecting
immediate-early CMV promoted vectors expressing the
human pre-Mir-548am-5p or the anti-miR-548am-5p
(SBI) and the VSV-G protein by Lipofectamine 2000
(Invitrogen). Transfected 293 GPR cells were induced 8 h
post-transfection with 5 mM sodium butyrate and 2 μM
of PonA. Twenty hours later, supernatants were replaced
with fresh medium containing the inducers. LVS con-
taining supernatants were finally harvested 24 and 48 h
later, clarified, and concentrated by ultracentrifugation on
20% sucrose cushion 100,000 × g, 2 h at 4 °C. LVS pre-
parations were titrated by measuring HIV-1 CAp24 con-
tents by quantitative ELISA (Innogenetics, Gent,
Belgium).
Primary cells transduction
DFs from four male donors were transduced to over-
express miR-548am-5p and four female donors were
transduced to downregulate miR-548am-5p. One hun-
dred nanograms of HIV-1 CAp24 equivalents of LVS/105
cells were adsorbed on DFs by spinoculation at 150 × g for
30 min at room temperature. Afterwards, cells were re-fed
by adding fresh medium, incubated at 37 °C and harvested
48 h later. Parallel DF cultures were treated with 50 μM
zidovudine (AZT), 30 min at 37 °C before transduction
and used as controls for the specific lentivirus effect.
Harvested cells were examined for transduction efficiency
by flow cytometer analysis by quantification of GFP-
positive cells. GFP-transduced cells were sorted to 99%
purity by fluorescence-activated cell sorting (FACS) using
a BD Biosciences cytometer (FACS Aria; BD Biosciences,
San Jose, CA). Either GFP-negative or -positive cells were
subsequently analyzed for miR-548am-5p level, Bax and
Bcl-2 expression, and apoptotic susceptibility.
Chemicals and reagents
All chemicals were the highest grade available from
Sigma-Aldrich (St. Louis, MO, USA), unless otherwise
indicated. 5,5,6,60-tetra-chloro-1,10,3,30-tetraethyl-ben-
zimidazolyl-carbocyanineiodide (JC-1), tetra-
methylrhodamine (TMRM), monochlorobimane (MCB),
and MitoSOX were all purchased from Life Technologies
Corporation.
Flow cytometry analyses
Mitochondrial membrane potential
The mitochondrial membrane potential (MMP) of DFs
was studied by using JC-1 or TMRM (both Life Tech-
nologies Corporation). In line with this method, living
cells were stained with 10 μM of JC-1 or with
1 μM TMRM.
Cell death
Quantitative evaluation of apoptosis was performed by a
double staining flow cytometry method using FITC-
conjugated Annexin V or APC-conjugated Annexin V
(Life Technologies Corporation) and Trypan blue (TB)
(Marine Biological Laboratory, MBL, Woods Hole, MA,
USA) according to the manufacturer’s protocol.
Reacting Oxygen Species
Living cells were incubated in Hank’s balanced salt
solution, pH 7.4, with dihydrorhodamine 123 (DHR123,
Thermo Fisher) in polypropylene test tubes for 15 min at
37 °C (final concentration 10 μM). DHR123 dye freely
diffuses into cells and is primarily oxidized by H2O2
producing green fluorescence.
Mitochondrial reacting oxygen species
Living cells (5 × 105) were incubated with 5 μM Mito-
SOX (Red Mitochondrial Superoxide Indicator; Thermo
Fisher, Eugene, OR) in complete medium, for 30min at
37 °C. Cells were then washed in phosphate-buffered
saline (PBS) and immediately analyzed on a cytometer.
Glutathione
Following the same protocol, glutathione (GSH) intra-
cellular content was evaluated by using MCB (Thermo
Fisher). Samples were washed twice in ice-cold PBS and
immediately acquired by an LRS II cytometer (Becton and
Dickinson, San Jose, CA, USA) equipped with a
UVB laser.
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Quantitative evaluation of proteins
DFs were fixed with 4% paraformaldehyde (Carlo Erba,
Milano, Italia) and then permeabilized by 0.5% Triton X-
100 (Sigma-Aldrich). After washings, cells were incubated
for 1 h at 4 °C with the following antibodies, alone or in
combination, at a final concentration of 0.1 mg/ml: MAb
to Bcl-2 (Santa Cruz Biotechnology, Inc., CA, USA); MAb
anti-APAF-1 (Abcam, Cambridge, UK), PAb anti-BAX
(Cell Signaling, New England Biolabs, UK), PAb anti-Bcl-
xL (Santa Cruz), and MAb anti-XIAP (Cell Signaling) for
1 h at 4 °C. After washings, cells were incubated for
30min at 37 °C with an anti-mouse antibody conjugated
with Cy5 and/or with an anti-rabbit conjugated with PE
(both Abcam). Cell samples were washed twice in PBS
and immediately analyzed on a cytometer.
Data and statistics
For flow cytometry studies, where not otherwise speci-
fied, samples were analyzed with a FACScalibur cytometer
(BD Biosciences) equipped with a 488 argon laser and
with a 635 red diode laser. At least 30,000 events were
acquired. Data were recorded and statistically analyzed by
a Macintosh computer using CellQuest software (BD
Biosciences). The expression level of the analyzed proteins
was expressed as median fluorescence. Collected data
analysis was carried out by ANOVA two-way testing for
repeated samples, using Graph Pad software (Graph Pad,
San Diego, CA, USA). All data were verified in at least
three independent experiments and are reported as
means ± standard deviation (SD). Only values of p < 0.01
were considered as significant.
Results
miR-548am-5p is differentially expressed in XX and XY
cells
Based on the bioinformatic analysis described in Materials
and methods, miR-548am-5p resulted possibly expressed at
different levels in XX and XY cells. Two additional miRs,
miR23c and miR548ax, were considered as controls. These
three miRs regulate a number of genes (663, listed in Table
S5), in particular miR-548ax and miR-548am-5p regulate
some genes that are involved in very important pathways
affecting cell fate, such as p53 pathway, apoptosis, and
protein ubiquitination (Table S6). To test whether the
prediction of our in silico analysis was correct, we tested the
expression of these three miRs by qRT-PCR in primary DFs
from eight male and eight female subjects.
The results shown in Fig. 1a (left panel) indicate that miR-
548am-5p is the most differently expressed, being about
fivefold overexpressed in XX DFs with respect to XY ones,
whereas miR-23c and miR-548ax were equally expressed in
both sexes. To further test whether this differential
expression may have an effect on apoptosis susceptibility,
we investigated the expression of specific target genes of
miR548am-5p. Among these target genes, some apoptosis-
related genes were predicted and experimentally validated,
such as apoptotic peptidase activating factor 1 (APAF1), X-
linked inhibitor of apoptosis protein (XIAP), B-cell lym-
phoma 2 (Bcl-2), Bcl-2-associated protein X (Bax), and Bcl-
2-like 1 (Bcl-xL). Based on this, we first quantitated the
levels of these proteins in XY and XXDFs. As shown in Fig. 1a
(right panel), we did not observe any significant difference
in the expression of APAF1, Bcl-xL, or XIAP between XY
and XX DFs. In contrast, significant sex-related differ-
ences in the expression levels of Bax and Bcl-2 proteins
were detected. In particular, in XY DFs, the Bax level was
significantly higher and the Bcl-2 level was significantly
lower (about threefold) than in XX ones. Consequently
the Bax/Bcl-2 ratio was threefold higher in XY compared
to XX DFs (Fig. 1b).
In addition, in XY DFs we also observed a significantly
higher production of mitochondrial Reacting Oxygen
Species (Fig. 1c), paralleled by a hyperpolarization of
MMP(assessed using TMRM or JC-1) in comparison with
XX DFs (Fig. 1d).
Anti-apoptotic proteins such as Bcl-2 bind and
sequester pro-apoptotic proteins, including Bax, to reg-
ulate the mitochondrial pathway of apoptosis, by con-
trolling the permeabilization of the outer mitochondrial
membrane41. We therefore compared the apoptotic pro-
neness of XY and XX DFs after treatment with cyclo-
heximide (5 μM, CHX), an inhibitor of protein synthesis,
and TNF-α (100 ng/ml), which trigger mitochondrial-
dependent cell death pathway42. Following the pro-
apoptotic treatment (CHX+TNF-α) for 18 h, about 50%
of XY DFs and about 20% of XX DFs underwent apoptotic
death (Fig. 2a). Accordingly, cytofluorimetric analysis
showed a significant drop of MMP after treatment with
CHX+TNF-α in XY but not XX DFs (Fig. 2b). Cell
treatment with CHX or TNF-α alone was largely inef-
fective in inducing cell death, with no difference between
XX and XY DFs. In particular, after CHX administration
we found 7.1 ± 3.1% and 6.3 ± 2.3% of apoptotic cells in
XY and XX DFs, respectively (p > 0.05 vs untreated cells),
whereas TNF-α induced apoptosis in 9.2 ± 4.1% of XY
DFs and in 6.7 ± 3.3 of XX DFs. Interestingly, a similar sex
difference was found when a different apoptotic stimula-
tion was used, i.e. 50 nM Staurosporine, overnight (XY
DFs 21.4 ± 7.6; XX DFs 9.7 ± 5.4; XY vs XX DFs, p < 0.01)
(data not shown).
Collectively these results indicated that male derived
DFs were more prone to mitochondria-mediated apop-
tosis than female ones.
Effects of overexpression of miR548am-5p in XY DFs
In order to verify whether the above-mentioned biolo-
gical differences could be due to the different levels of
miR548am-5p, we overexpressed this miR in DFs isolated
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Fig. 1 (See legend on next page.)
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from four different male subjects, by transduction with
GFP-miR548am-5p-carrying lentivirus. Forty-eight hours
after transduction, GFP-positive cells were sorted by
FACS and level of miR548am-5p was determined by qRT-
PCR. An average of 24.2 ± 5.3% of transduced GFP-
positive cells was obtained (Fig. 3a, central panel, Fig.
S1A). Upon transduction, the miR548am-5p level
increased by almost four times with respect to the GFP-
negative controls and by 1.7-fold compared to the mock-
transduced cells (Fig. S1B). The significant difference in
percentage of transduced cells (2 ± 0.43%) found in DFs
treated with 50 μM of the inhibitor of lentivirus replica-
tion, AZT, indicated that miR548am-5p effect in male
cultures was specific (Fig. 3a, right panel, Fig. S1A). In
parallel, we evaluated by flow cytometry the levels of Bax
and Bcl-2 proteins in both GFP-positive and -negative
cells. As shown in Fig. 3b, we observed significant dif-
ferences in the expression of Bax and Bcl-2 between the
two cell populations. In particular, in GFP-positive cells
we observed a significant reduction of Bax and a mild
increase of Bcl-2 levels, with a consequent decrease of
Bax/Bcl-2 ratio in comparison to GFP-negative cells
(Fig. 3b). Consistently, we detected a significant (p < 0.01)
reduction of CHX+TNF-α-induced apoptosis levels in
GFP-positive vs GFP-negative cells (Fig. 3c). In Fig. S2 the
analyses obtained in a second, independent round of
experiments using DFs isolated from three additional
male subjects are reported. In few words, the over-
expression of miR548am-5p in XY cells leads to an
increased resistance to apoptotic cell death, thus reverting
the natural proneness of XY cells to undergo apoptosis.
Effects of down-regulation of miR548am-5p in XX DFs
On the basis of the above results, the “reverse” experi-
ment was then carried out: miR-548am-5p was down-
regulated by transduction with anti-miR-548am-5p-car-
rying lentiviral construct containing GFP in DFs isolated
from four female donors. These experiments were carried
out in cells pre-treated or not with AZT. Consistently
with previous reports43, transduction efficiency of XX DFs
was significantly lower than that observed in XY ones
(10.5 ± 1.8; Fig. 4a, central panel, Fig. S1C).
Forty-eight hours after transduction, GFP-positive cells
were sorted by FACS and the level of miR548am-5p,
quantitated by qRT-PCR, decreased by 55% compared to
the GFP-negative controls (Fig. S1D).
Consistently with the reduced level of the miR548am-
5p, the expression of the target protein Bax resulted
increased whereas Bcl-2 expression was reduced in GFP-
positive XX DFs. As a consequence, the Bax/Bcl-2 ratio
increased significantly in transduced cells (Fig. 4b).
Accordingly, a significant increase of apoptosis in trans-
duced XX DFs upon treatment with CHX+TNF-α was
observed (Fig. 4c). Also, in XX DFs, transduction per se
induced a certain cytotoxic effect, as shown in Fig. 4c.
Figure S3 shows the analyses obtained in a second,
independent round of experiments using DFs isolated
from three additional female subjects. In few words, the
down-regulation of miR548am-5p in XX cells leads to an
increased susceptibility to apoptotic cell death, reverting
the natural attitude of XX cells to be resistant to apoptotic
stimulus.
Discussion
Sexual dimorphism is ubiquitous across vertebrates, in
which both sexes exhibit differences in behavioral, mor-
phological, and physiological trait. There is still some
debate, but it is accepted that natural selection and/or
sexual selection are important for the appearance of
sexual dimorphism44, in which ecological and
(see figure on previous page)
Fig. 1 a Left panel: Expression level of the selected microRNAs in XX and XY DFs as quantitatively measured by qRT-PCR. The values of fold increase
were calculated by the 2−ΔΔCt method for each sample relative to the overall female or male samples mean. The fold increase values were obtained
from eight female and eight male donors estimated in two independent quantitation reactions, with triplicate wells for each sample and for each
microRNA. Right panel: Cytofluorimetric analysis of APAF1, Bcl-xL, and XIAP expression level in DFs isolated from eight male and eight female healthy
donors obtained in three independent measures performed in each donor and reported as mean ± SD of the median fluorescence intensity. No
statistically significant differences were evident between male and female DFs. b Left panel: Cytofluorimetric analysis of Bax and Bcl-2 expression level
in DFs isolated from eight male and eight female (right panel) healthy donors obtained in three independent measures performed in each donor and
reported as mean ± SD of the median fluorescence intensity. Central panel: Dot plots obtained in two representative XY and XX DFs after double cell
staining with Bax and Bcl-2 specific antibodies. Right panel: Bar graph showing the ratio Bax/Bcl-2 obtained by pooling together measures acquired
in DFs isolated from all the male or female donors. c Left panel: Bar graph showing a representative flow cytometric evaluation, performed by using
MitoSOX-red, of mitochondrial ROS production in DFs isolated from eight male and eight female healthy donors. Central panel: Bar graph showing
mitochondrial ROS production obtained by pooling together measures acquired in DFs isolated from all the male or female donors and reported as
mean ± SD of the median fluorescence intensity. Right panels: Cytofluorimetric histograms of mitochondrial ROS evaluation obtained in two
representative male and female DFs. d Left panel: Bar graph showing a representative flow cytometric evaluation, performed by using TMRM, of
mitochondrial membrane potential (MMP) in DFs isolated from eight male and eight female healthy donors. Central panel: Bar graph showing MMP
obtained by pooling together measures acquired in DFs isolated from all the male or female donors and reported as mean ± SD of the median
fluorescence intensity. Right panels: Cytofluorimetric histograms of MMP evaluation obtained in two representative XY and XX DFs. Black columns XY
DFs; gray columns XX DFs. *p < 0.01 between XY and XX DFs
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environmental factors may induce dimorphic traits in
females and males harboring highly similar genome. In
fact, most of the phenotypic differences are caused by a
sex-biased expression of genes45, which can depend on
their regulation at the transcriptional and post-
transcriptional levels, and regulators such as miRs are
reported to have important roles in this process46.
MiRs are endogenous small non-coding RNAs with a
total length of about 19–25 nucleotides that exert a wide
range of biological functions in different cellular pro-
cesses, including differentiation, proliferation, metabo-
lism, and apoptosis. MiRs can act at post-transcriptional
level by inhibiting the translation of target mRNAs or
directly stimulating mRNA degradation via binding the 3′
untranslated region (UTR) of target genes47, and it is
believed that more than 30% of human genes are regu-
lated by miRs.
Recent studies suggested that sex-related differences are
present in the control of cell death programs48. As a
general rule, XY and XX cells appear differently respon-
sive to injuries possibly because of their different cap-
abilities to face cellular stress49. Accordingly, it was
observed that the same stressors preferentially induce
apoptosis in XY cells and autophagy in XX cells, which
Fig. 2 a Left panel: Bar graph showing flow cytometry analysis after staining with Annexin V-APC obtained in DFs isolated from eight male and eight
female healthy donors reported as means ± SD. Right panel: Flow cytometry histograms of apoptosis evaluation obtained in one representative cell
line of XY and XX DFs. Numbers represent the percentages of Annexin V-positive cells. b Left panel: Bar graph showing MMP obtained by pooling
together measures acquired in DFs isolated from all the male or female donors and reported as mean ± SD of the median fluorescence intensity.
Right panels: Cytofluorimetric histograms of MMP evaluation obtained in one representative cell line of XY and XY DFs. *p < 0.01 between XY
and XX DFs
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can lead to cell survival38,50,51. Interestingly, this phe-
nomenon has been observed not only in transformed cell
lines but also in non-transformed cells freshly isolated
from male or female human or animal tissues, e.g., human
fibroblasts52, endothelial and smooth muscle cells, and rat
microvascular cells. This different susceptibility has been
connected to the content of reduced glutathione, which
resulted more elevated in XX cells37,53,54. Another possi-
ble reason is the differential expression of regulatory
elements such as miRs. A number of miRs is reported to
be differentially expressed between men and women24. In
this study, eight different datasets of miR expression were
investigated and identified 73 female-biased miRNAs and
163 male-biased miRNAs across four tissues. These
datasets were generated from miR expression analyses.
We used a different approach, based on an a priori
identification of miRs based on database exploration. In
order to provide a proof of principle of the validity of this
method, we investigated the expression of X-linked miRs
in normal DFs from male and females subjects. We have
found a number of miRs that are associated to XCI
escaper genes. One of these miRs, miR-548-am-5p,
resulted in fact much more expressed in XX cells. This
miR is involved in the regulation of genes, among others,
that are part of the P53 pathway, i.e. Bax, which represents
a key actor in mitochondrial-mediated apoptosis55.
Fig. 3 a Side scatter vs FL1 (GFP) dot plots obtained in one representative XY DFs cell line untransduced or transduced with GFP-miR548am-5p in the
presence or absence of AZT. Numbers indicate the percentage of GFP-positive cells. b Cytofluorimetric histograms of Bax and Bcl-2 expression level
in GFP-negative and -positive cells obtained in one representative XY DFs cell line after transduction with GFP-miR548am-5p. Numbers indicate the
median fluorescence intensity. Bar graph on the right shows the ratio Bax/Bcl-2 of four XY DFs cell lines. *p < 0.01 between GFP-positive and GFP-
negative cell populations. c Flow cytometry histograms of apoptosis evaluation in GFP-positive or -negative cell populations of one representative XY
DFs cell line after transduction with GFP-miR548am-5p treated or not with CHX+TNF-α. Numbers represent the percentages of annexin V-positive
cells. Bar graph showing flow cytometry analysis after cell staining with Annexin V-APC performed in triplicate and reported as means ± SD of four XY
DFs cell lines
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Consistently, and in agreement with our previous results,
the susceptibility to apoptosis resulted much higher in XY
DFs than in XX DFs.
In the mitochondrial pathway of apoptosis, various
types of stressors may cause translocation of pro-
apoptotic proteins of the Bcl-2 family, e.g. Bax from the
cytosol to the mitochondria where it can undergo oligo-
merization, resulting in increased mitochondrial perme-
ability, release of cytochrome c from the mitochondria,
and, finally, apoptosis execution56. The expression of this
gene is regulated by the tumor suppressor P53 and has
been shown to be involved in P53-mediated apoptosis.
Thus, it is reasonable to assume that the higher Bax/Bcl-2
ratio found in XY DFs, compared to XX DFs, could be
responsible for, or contribute to, the different apoptotic
proneness observed between XY and XX DFs by favoring
Bax oligomerization, release of cytochrome c from the
mitochondria with a consequent mitochondrial mem-
brane depolarization and, ultimately, apoptosis. On the
basis of our results, we can state that miR548am-5p has a
significant role in this sex-based difference in apoptosis
susceptibility observed in DFs. In fact, in XY DFs trans-
duced with miR548am-5p, we observed a significantly
reduced Bax/Bcl-2 ratio and an increased resistance to
Fig. 4 a Side scatter vs (FL1) GFP dot plots obtained in one representative XX DFs cell line untransduced or transduced with GFP-anti-miR548am-5p
in the presence or absence of AZT. Numbers indicate the percentage of GFP-positive cells. b Cytofluorimetric histograms of Bax and Bcl-2 expression
level in GFP-negative and -positive cells obtained in one representative XX DFs cell line after transduction with GFP-anti-miR548am-5p. Numbers
indicate the median fluorescence intensity. Bar graph on the right shows the ratio Bax/Bcl-2 of four XX DFs cell lines. *p < 0.01 between GFP-positive
and GFP-negative cells. c Flow cytometry histograms of apoptosis evaluation in GFP-positive or -negative cells of one representative XY DFs cell line
after transduction with GFP-anti-miR548am-5p treated or not with CHX+TNF-α. Numbers represent the percentages of Annexin V-positive cells. Bar
graph showing flow cytometry analysis after cell staining with Annexin V-APC performed in triplicate and reported as means ± SD of four XX DFs
cell lines
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CHX+TNF-α-induced apoptosis. Conversely, in XX DFs
transduced with anti-miR548am-5p we observed a sig-
nificant increase of both Bax/Bcl-2 ratio and susceptibility
to CHX+TNF-α-induced apoptosis.
Very interestingly, the diverse transduction efficiency
we observed between male and female DFs is consistent
with other reports that showed reduced transduction
efficiency of female cells and animals with viral vectors43.
Although this evidence was not discussed previously, in
the present study, we can hypothesize that the expression
of VSV-G receptor (used as cell entry molecule) is
expressed at lower titer on XX cells. Alternatively, given
the reported evidence that female cells develop a more
intense innate immune response than male cells57, it is
conceivable that the lentivirus replication is contrasted in
XX DFs resulting in a reduced number of GFP-
positive cells.
It has been suggested that genes escaping XCI may
account for the differential sensitivity of females to some
diseases. For example, the inactive X chromosome fre-
quently reactivates in cancers, mainly in breast cancer,
and some of these sleeping genes can reawake as women
age. We provide here a further actor in this scenario: the
XCI-escaping miRs. In fact, our results demonstrate that
the sex-specific susceptibility to apoptosis of DFs can be
explained, at least in part, by the differential expression
level and activity of a XCI-escaping miR, the miR-
548am-5p. A number of questions remain open,
including the importance of this phenomenon for tis-
sues and cell types other than DFs, and the biological
interaction between miR548am-5p and its BCL2 and
Bax mRNA targets. Further studies are needed to clarify
these important points; however, these data may pave
the way for a new perspective on sex-specific suscept-
ibility (or resistance) to the onset of many diseases as
well as on sex-specific diseases prevention and
treatment.
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